Celltrion, Inc. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2025-00456
Filing Date Jan 15, 2025
Institution Decision Date Jun 25, 2025
Decision Date Jun 25, 2025
Court Patent Trial and Appeal Board
Status Discretionary Denial
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
Petitioner
Patent Owner
Petitioner Attorneys
7Celltrion
Attorney Name: Lora M. Green
Gemini Law LLP
Celltrion
Attorney Name: Keith A. Zullow
Gemini Law LLP
Celltrion
Attorney Name: Michael W. Johnson
Willkie Farr & Gallagher
Celltrion
Attorney Name: Aviv Zalcenstein
Gemini Law LLP
Celltrion
Attorney Name: Michael Cottler
Gemini Law LLP
Celltrion
Attorney Name: Robert Cerwinski
Gemini Law LLP
Celltrion
Attorney Name: Franklin Chu
Gemini Law LLP
Patent Owner Attorneys
5Regeneron Pharmaceuticals
Attorney Name: David I. Berl
Williams & Connolly
Regeneron Pharmaceuticals
Attorney Name: Andrew V. Trask
Williams & Connolly
Regeneron Pharmaceuticals
Attorney Name: Arthur J. Argall III
Williams & Connolly
Regeneron Pharmaceuticals
Attorney Name: Elizabeth S. Weiswasser
Paul Weiss Rifkind Wharton & Garrison
Regeneron Pharmaceuticals
Attorney Name: Priyata Y. Patel
Paul Weiss Rifkind Wharton & Garrison
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11084865 | VEGF antagonist formulations suitable for intravitreal administration | Aug 10, 2021 |
